Sangamo Therapeutics Announces Third Quarter 2024 Conference Call and Webcast
Sangamo Therapeutics (Nasdaq: SGMO) has announced it will release its third quarter 2024 financial results after market close on Tuesday, November 12, 2024. The company will host a conference call at 4:30 p.m. Eastern on the same day to discuss financial results and provide business updates. Participants can register for the call through a provided link and are advised to join 10 minutes before the start. The webcast will be available on Sangamo's website in the Investors and Media section, with a replay accessible afterward.
Sangamo Therapeutics (Nasdaq: SGMO) ha annunciato che rilascerà i propri risultati finanziari del terzo trimestre 2024 dopo la chiusura del mercato martedì 12 novembre 2024. L'azienda ospiterà una conferenza telefonica alle 16:30 ora orientale dello stesso giorno per discutere i risultati finanziari e fornire aggiornamenti aziendali. I partecipanti possono registrarsi per la chiamata tramite un link fornito e sono invitati a unirsi 10 minuti prima dell'inizio. La trasmissione in webcast sarà disponibile sul sito web di Sangamo nella sezione Investitori e Media, con una registrazione accessibile successivamente.
Sangamo Therapeutics (Nasdaq: SGMO) ha anunciado que publicará sus resultados financieros del tercer trimestre de 2024 después del cierre del mercado el martes 12 de noviembre de 2024. La compañía llevará a cabo una conferencia telefónica a las 4:30 p.m. hora del Este el mismo día para discutir los resultados financieros y proporcionar actualizaciones sobre el negocio. Los participantes pueden registrarse para la llamada a través de un enlace proporcionado y se les aconseja unirse 10 minutos antes del comienzo. La transmisión en línea estará disponible en el sitio web de Sangamo en la sección de Inversores y Medios, con una grabación accesible posteriormente.
상가모 테라퓨틱스 (Nasdaq: SGMO)는 2024년 3분기 재무 결과를 2024년 11월 12일 화요일 시장 마감 후 발표한다고 발표했습니다. 회사는 같은 날 동부 시간 기준 오후 4시 30분에 재무 결과를 논의하고 비즈니스 업데이트를 제공하기 위해 컨퍼런스 콜을 개최할 예정입니다. 참가자는 제공된 링크를 통해 전화에 등록할 수 있으며, 시작 10분 전에 접속할 것을 권장합니다. 웹캐스트는 상가모의 웹사이트 투자자 및 미디어 섹션에서 제공되며, 이후 리플레이가 가능합니다.
Sangamo Therapeutics (Nasdaq: SGMO) a annoncé qu'il publiera ses résultats financiers du troisième trimestre 2024 après la clôture des marchés le mardi 12 novembre 2024. L'entreprise animera une conférence téléphonique à 16h30, heure de l'Est, le même jour pour discuter des résultats financiers et fournir des mises à jour commerciales. Les participants peuvent s'inscrire à l'appel via un lien fourni et sont invités à se connecter 10 minutes avant le début. Le webinaire sera disponible sur le site Web de Sangamo dans la section Investisseurs et Médias, avec une rediffusion accessible par la suite.
Sangamo Therapeutics (Nasdaq: SGMO) hat angekündigt, dass es seine Finanzergebnisse für das dritte Quartal 2024 nach Börsenschluss am Dienstag, den 12. November 2024, veröffentlichen wird. Das Unternehmen wird am selben Tag um 16:30 Uhr Eastern Zeit eine Telefonkonferenz abhalten, um die Finanzergebnisse zu besprechen und Geschäftsaktualisierungen bereitzustellen. Teilnehmer können sich über einen bereitgestellten Link für die Konferenz registrieren und werden gebeten, 10 Minuten vor Beginn beizutreten. Der Webcast wird auf der Website von Sangamo im Bereich Investoren und Medien verfügbar sein, mit einer späteren Zugriffsmöglichkeit auf die Wiederholung.
- None.
- None.
The company will hold a conference call at 4:30 p.m. Eastern on Tuesday, November 12, which will remain open to the public. During the conference call, the company will review its financial results and provide business updates.
Participants should register for, and access, the call using this link. While not required, it is recommended to join 10 minutes prior to the event start. Once registered, participants will be given the option to either dial into the call with the number and unique passcode provided, or to use the dial-out option to connect their phone instantly. The link to access the live webcast can also be found on the Sangamo Therapeutics website in the Investors and Media section under Events.
A replay will be available following the conference call, accessible under Events.
About Sangamo Therapeutics
Sangamo Therapeutics is a genomic medicine company dedicated to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases who do not have adequate or any treatment options. Sangamo believes that its zinc finger epigenetic regulators are ideally suited to potentially address devastating neurological disorders and that its capsid discovery platform can expand delivery beyond currently available intrathecal delivery capsids, including in the central nervous system. Sangamo’s pipeline also includes multiple partnered programs and programs with opportunities for partnership and investment. To learn more, visit www.sangamo.com and connect with us on LinkedIn and X.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241104090881/en/
Investor Relations & Media Inquiries
Louise Wilkie
ir@sangamo.com
media@sangamo.com
Source: Sangamo Therapeutics, Inc.
FAQ
When will Sangamo Therapeutics (SGMO) release Q3 2024 earnings?
What time is Sangamo Therapeutics (SGMO) Q3 2024 earnings call?
Where can I access Sangamo Therapeutics (SGMO) Q3 2024 earnings webcast?
